Brontictuzumab (OMP 52M51) is a моноклональный антитело (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor клетка proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma.
Brontictuzumab (OMP 52M51) is a monoclonal antibody (MAb) that inhibits Notch1 signal. Brontictuzumab selectively binds the negative regulatory region of the Notch1. Brontictuzumab inhibits tumor cell proliferation. Brontictuzumab can be used in the research of leukemia and lymphoma.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.